Co-immunostaining with Coilin revealed that FUS is nucleoplasmic and exhibits clear localization in CBs only in LNCaP cells of the prostate cancer cell lines tested (Fig. 6, Additional file 1: Figure S5). Here, FUS is linked to prostate carcinoma.